Video Latest - ecancer

METEOR trial results: Cabozantinib improves advanced kidney cancer survival

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

26 Sep 2015

Atrial fibrillation in CLL patients on ibrutinib

Prof Florence Cymbalista – University of Paris, Paris, France

10 Sep 2015

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL

Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia

10 Sep 2015

Tumour specific immunotherapy in CLL

Prof Catherine Wu - Harvard Medical School, Boston, USA

9 Sep 2015

Highlights from iwCLL 2015

Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia

9 Sep 2015

Cytogenetic and proteomic prognostic markers of CLL

Dr Lauren Thurgood - Flinders University, Adelaide, South Australia

9 Sep 2015

Predicting progression and survival in CLL

Prof Jonathan Strefford - University of Southampton, Southampton, UK

9 Sep 2015

Phase I study of duvelisib in patients with relapsed or refractory CLL

Dr Susan O’Brien – University of California, Irvine, California, USA

$Phase I study of duvelisib in patients with relapsed or refractory CLL ( Dr Susan O’Brien – University of California, Irvine, California, USA )$

9 Sep 2015

The LRF CLL4 trial: long-term outcomes

Prof Daniel Catovsky - The Institute of Cancer Research, London, UK

9 Sep 2015

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

9 Sep 2015

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells

Dr Alexey Danilov - Oregon Health and Science University, Portland, USA

9 Sep 2015

Genetic deletions in CLL

Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA

9 Sep 2015

Video